BAT4406F
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for BAT4406F, covering 2025-07-10 to 2026-04-03. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Study of BAT4406F Injection in Patients With Minimal Change Disease/Focal Segmental Glomerulosclerosis [Phase 2, Phase 3]